Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT06374420
Brief Summary:
The aim of this work is to estimate the frequency of small airway disease and/or the bronchial hyperreactivity in follow up of postacute covid survivors.
Detailed Description:
This is a observational longitudinal study investigating pulmonary sequelae of covid-19.
Study site:
Mansoura university hospital, chest department and post covid outpatient clinic.
Elmahalla chest hospital and outpatients clinic.
Time of study :
Two years from September 2021 to September 2023
Target population:
Adults with confirmed covid 19 who remaining symptomatic after 30 days from the diagnosis.
Sample size The study will include 100 selected cases during period from 2021 to 2023
Patients :
The enrolled patients are adults who survived acute covid-19 and presented for clinical follow up.
Study:
NCT06374420
Study Brief:
Protocol Section:
NCT06374420